A new trading day began on Monday, with Metagenomi Inc (NASDAQ: MGX) stock price up 3.21% from the previous day of trading, before settling in for the closing price of $2.18. MGX’s price has ranged from $1.23 to $5.50 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged -3.60%. With a float of $21.80 million, this company’s outstanding shares have now reached $37.38 million.
The firm has a total of 202 workers. Let’s measure their productivity. In terms of profitability, gross margin is 100.0%, operating margin of -193.73%, and the pretax margin is -184.18%.
Metagenomi Inc (MGX) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Metagenomi Inc is 41.67%, while institutional ownership is 25.44%. The most recent insider transaction that took place on Jul 09 ’25, was worth 1,470,404. Before that another transaction happened on Jun 06 ’25, when Company’s insider sold 199 for $1.75, making the entire transaction worth $348. This insider now owns 16,693 shares in total.
Metagenomi Inc (MGX) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.60% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Here are Metagenomi Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.86.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.10, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.08 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Analysing the last 5-days average volume posted by the [Metagenomi Inc, MGX], we can find that recorded value of 1.5 million was better than the volume posted last year of 0.71 million. As of the previous 9 days, the stock’s Stochastic %D was 74.84%.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 71.83%, which indicates a significant decrease from 79.25% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.17 in the past 14 days, which was higher than the 0.14 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.64, while its 200-day Moving Average is $2.11. Now, the first resistance to watch is $2.35. This is followed by the second major resistance level at $2.46. The third major resistance level sits at $2.58. If the price goes on to break the first support level at $2.13, it is likely to go to the next support level at $2.01. Should the price break the second support level, the third support level stands at $1.90.
Metagenomi Inc (NASDAQ: MGX) Key Stats
With a market capitalization of 84.11 million, the company has a total of 37,381K Shares Outstanding. Currently, annual sales are 52,300 K while annual income is -78,060 K. The company’s previous quarter sales were 4,130 K while its latest quarter income was -25,040 K.
